Tumor Delivery of Chemotherapy Combined with Inhibitors of Angiogenesis and Vascular Targeting Agents

Numerous angiogenesis-vascular targeting agents have been admitted to the ranks of cancer therapeutics; most are used in polytherapy regimens. This review looks at recent progress and our own preclinical experience in combining angiogenesis inhibitors, mainly acting on VEGF/VEGFR pathways, and vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesca, Marta, Bizzaro, Francesca, Zucchetti, Massimo, Giavazzi, Raffaella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787308/
https://www.ncbi.nlm.nih.gov/pubmed/24102047
http://dx.doi.org/10.3389/fonc.2013.00259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787308/
https://www.ncbi.nlm.nih.gov/pubmed/24102047
http://dx.doi.org/10.3389/fonc.2013.00259

Ejemplares similares